| 183 | 8 | 149 |
| 下载次数 | 被引频次 | 阅读次数 |
目的:分析探讨尺肤针介入中药疗法对腹泻型肠易激综合征(IBS-D)患者的临床效果及对其疼痛管理、血清γ-干扰素(IFN-γ)、5-羟色胺(5-HT)水平的影响。方法:选取2019年7月至2021年7月邯郸市中医院收治的351例IBS-D患者为治疗对象,按随机数字表法分为针药组、中药组、西药组,每组患者117例。西药组以匹维溴铵片治疗,中药组在西药组基础上以痛泻逍遥方内服治疗,针药组在中药组基础上以尺肤针介入治疗。比较三组患者临床疗效、症状及疼痛程度评分、血清学指标水平、肠道屏障功能指标、治疗安全性。结果:针药组总有效率为91.45%(107/117),高于中药组的82.05%(96/117),且高于西药组的75.21%(88/117)(P<0.05)。治疗后针药组患者中医证候评分、腹胀评分、腹泻评分、腹痛评分均低于中药组、西药组(P<0.05)。治疗后与治疗前比较,三组IFN-γ、5-HT水平均有降低(P<0.01),且治疗后针药组IFN-γ、5-HT表达水平均低于中药组、西药组(P<0.05)。治疗后针药组患者的D-乳酸(D-LA)、二胺氧化酶(DAO)、细菌内毒素(ET)水平均低于中药组、西药组(P<0.05)。治疗期间三组患者的不良反应发生率为9.40%(11/117)、6.84%(8/117)、5.98%(7/117)(P>0.05)。结论:尺肤针介入中药疗法对IBS-D患者有良好的治疗效果,能有效缓解患者的症状和疼痛程度,抑制患者IFN-γ、5-HT表达,改善患者肠道黏膜屏障功能,有较好的安全性。
Abstract:Objective:To analyze and explore the clinical effect of Chifu acupuncture combined with Chinese medicinal treatment on irritable bowel syndrome with diarrhea(IBS-D),and influence on pain management and levels of serum interferon-γ(IFN-γ) and 5-hydroxytryptamine(5-HT). Methods:From July 2019 to July 2021,351 patients with IBS-D hospitalized in Handan Hospital of Traditional Chinese Medicine were divided into three groups,acupuncture and drug group,Chinese medicinal group and western medicine group by random number table method,117 patients in each group. The western medicine group was treated with naverium bromide tablets,the Chinese medicinal group was treated with Tongxie Xiaoyao Formula besides the medicine in western medicine group,and the acupuncture drug group was treated with Chifu acupuncture besides the treatment in the Chinese medicinal group. The clinical efficacy,symptom and pain degree score,intestinal mucosal barrier function index,serological index level and treatment safety of the three groups were statistically compared.Results:In the acupuncture and drug group,total effective rate was 91.45%(107/117),higher than that in Chinese medicinal group,82.05%(96/117),and higher than that in western medicine group,75.21%(88/117)(P<0.05). The symptom scores of the three groups were improved compared with those before treatment,and the traditional Chinese medicine(TCM) symptom score,abdominal distension score,diarrhea score and abdominal pain score in the acupuncture and drug group were lower than those in the Chinese medicinal group and western medicine group after treatment(P<0.05). The levels of IFN-γ and 5-HT in the three groups decreased after treatment compared with before treatment(P<0.01),and the expression levels of IFN-γ and 5-HT in the acupuncture drug group were lower than those in the Chinese medicinal group and western medicine group(P<0.05). After treatment,the levels of D-lactic acid(D-LA),diamine oxidase(DAO)and bacterial endotoxin in the acupuncture and drug group were lower than those in the Chinese medicinal group and the western medicine group(P<0.05). The incidence of adverse reactions in the three groups during treatment was 9.40%(11/117),6.84%(8/117) and 5.98%(7/117),respectively(P>0.05). Conclusions:Chifu acupuncture combined with Chinese medicinal treatment is of good therapeutic effect on IBS-D. It could effectively alleviate the symptoms and pain degree of patients,inhibit the expression level of IFN-γ,5-HT,and improve the intestinal mucosal barrier function,with high safety.
[1] GIRI M,ROY S,NAHAR L,et al. Psychometric evaluation of the Bengali version of irritable bowel syndrome quality of life questionnaire:a cross-sectional study[J]. J Clin Sci,2021,18(1):42-48.
[2] SRISUKTHAVEERAT V,TORKAEW W,SRIDEE S,et al.Nutrition communication about low FODMAP diet in irritable bowel syndrome(IBS)and small intestinal bacterial overgrowth(SIBO)in Thai healthcare practitioners[J].Bioact Compd Health Dis,2021,4(6):93-98.
[3]魏延,吕丹丹,王成,等.中国军人肠易激综合征患病率Meta分析[J].华南国防医学杂志,2020,34(10):744-750.
[4]曲晓琳.布拉酵母菌联合氟哌噻吨美利曲辛治疗腹泻型肠易激综合征的临床效果观察[J].中国药物与临床,2020,20(9):1517-1519.
[5]程志成,翁丽芳,金峰.匹维溴铵在拟诊腹泻型肠易激综合征患者结肠镜检查肠道准备中的应用[J].实用中西医结合临床,2020,20(8):123-125.
[6]魏瑾瑶,成俊,黄芳.肠易激综合征的主要致病因素及中医药治疗[J].药学研究,2020,39(6):344-347.
[7]王维,赵海红,高社光.尺肤针联合中药治疗腹泻型肠易激综合征102例临床观察[J].中医杂志,2017,58(12):1033-1035.
[8]陈光华,李红君,舒波.痛泻四神汤联合马来酸曲美布汀与谷维素对腹泻型肠易激综合征患者血清IFN-γ、5-HT、NPY水平及T淋巴细胞亚群的影响[J].中国中西医结合消化杂志,2018,26(9):742-746.
[9]中华中医药学会脾胃病分会,温艳东,李保双,等.消化系统常见病肠易激综合征中医诊疗指南(基层医生版)[J].中华中医药杂志,2020,35(7):3518-3523.
[10]中华中医药学会脾胃病分会.肠易激综合征中医诊疗专家共识意见(2017)[J].中医杂志,2017,58(18):1614-1620.
[11]蔡林坤,黄适,彭卓嵛,等.安肠汤治疗腹泻型肠易激综合征肝郁脾虚证的临床疗效及其对肠屏障功能、炎性因子、神经肽Y水平的影响研究[J].中国全科医学,2020,23(9):1169-1174.
[12]王宁,毕宇峰,纪昌春,等.腹泻型肠易激综合征发病机制及针灸干预研究进展[J].辽宁中医药大学学报,2021,23(1):50-54.
[13] COLLYER R,CLANCY A,BORODY T. Faecal microbiota transplantation alleviates symptoms of depression in individuals with irritable bowel syndrome:a case series[J]. Med Microecol,2020,6(2):100029.
[14] VALDEZ-PALOMARES F,NAMBO-VENEGAS R,URIBEGARCAA J,et al. Intestinal microbiota fingerprint in subjects with irritable bowel syndrome responders to a low FODMAP diet[J]. Food Funct,2021,12(7):3206-3218.
[15]康年松,马伟明,洪妍,等.中医外治法治疗虚寒型功能性消化不良重叠腹泻型肠易激综合征临床研究[J].新中医,2020,52(5):81-83.
[16]李聪.针刺配合雷火灸治疗脾虚泄泻型肠易激综合征临床疗效观察[J].中医药学报,2020,48(3):56-60.
[17]覃宇,易玮,林树雄,等.腹针疗法治疗腹泻型肠易激综合征临床疗效观察简[J].中国针灸,2017,29(12):1265-1268.
[18]权春分,费景兰,刘慧莉.易医脐针治疗腹泻型肠易激综合征29例[J].中国针灸,2020,40(10):1136-1137.
[19]夏利显,周娇俐,梅丽俊,等.痛泻要方通过PI3K-AKT通路诱导细胞自噬治疗腹泻型肠易激综合征的机制[J].世界中西医结合杂志,2021,16(3):468-471,504.
[20]周毅,王晗,陈晓娟,等.痛泻要方加味结合艾灸治疗腹泻型肠易激综合征疗效和机制研究[J].浙江中西医结合杂志,2020,30(9):41-44.
[21]谢燕东,张静瑜,樊晴伶,等.参苓白术散联合复方谷氨酰胺肠溶胶囊对肠易激综合征患者的肠黏膜屏障功能及5-HT、IFN-γ、IL-8水平的影响[J].现代生物医学进展,2019,19(22):4269-4272.
[22]罗莎,唐少波,毛燕宁,等.基于5-HT探讨疏香灸治疗肝郁气滞证便秘型肠易激综合征的机制[J].中医药学报,2020,48(8):48-51.
基本信息:
DOI:10.16295/j.cnki.0257-358x.2023.08.011
中图分类号:R259
引用信息:
[1]王维,高社光,孙胜振,等.尺肤针结合中药疗法治疗腹泻型肠易激综合征临床研究[J],2023,42(08):836-841+904.DOI:10.16295/j.cnki.0257-358x.2023.08.011.
基金信息:
河北省中医药管理局科研计划项目(编号:2019378)